Too toxic, too untargeted, too difficult to prove. These assumptions about chemoprevention are being challenged by important developments in the search for preventive options tailored to specific risk factors in breast cancer. Recent years have [more]
The prospect is too exciting to dismiss: a single, inexpensive pill that, taken regularly, can reduce the risk of developing or dying from several types of cancer. The prospect is too exciting to dismiss: a [more]
Michael Sporn believes the best bet for controlling cancer is to pick up the warning signs and nip it in the bud. A pot of gold awaits any drugs company that can come up with [more]